Lapatinib-13C2,15N |
|
| Synonyms: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine-13C2,15N; GSK 572016-13C2,15N; GW 572016-13C2,15N; GW 572016X-13C2,15N; | |
| Cat. No.: L12532 | CAS No.: 1246819-07-7/ 231277-92-2(unlabelled) |
| MDL.: | Formula: C2713C2H26ClFN315NO4S |
| F.W.584.04 | Purity: 99% |
| Storage: -20˚C Freezer | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | L12532 | CAS No.: | 1246819-07-7/ 231277-92-2(unlabelled) | |
| MDL: | Formula: | C2713C2H26ClFN315NO4S | ||
| F.W.: | 584.04 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Pale Yellow Solid | M.P.: | >195°C (dec.) | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | -20˚C Freezer | Category: | Reference Standard | |
| Reference: | Kim, T.E., et al.: Drugs, 6, 886 (2003), Wood, E.R., et al.: Cancer Res., 64, 6652 (2004), Spector, N.L., et al.: J. Clin. Oncol., 23, 2502 (2005), | |||
| Application: | Labelled Lapatinib (L175800). Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic. | |||
| Category: | Isotope Labelled Compounds, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||